Patents-Review.com
🔗 Permalink
Assignee profile:

RETROTOPE, INC.

City:

Los Altos, California

Country:

United States

Published Applications:

21

Last publication date:

2024-03-21

Patent Grants:

19

Last grant date:

2022-11-29

Top Inventors for applications by RETROTOPE, INC.

These are the the leading inventors for applications assigned to RETROTOPE, INC.:

Recent patent applications by RETROTOPE, INC.

RETROTOPE, INC. based in Los Altos, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-03-21
US20240091188A1
Human necessities

Dosing Protocols for Administering Deuterated Arachidonic Acid or a Prodrug Thereof

 #2 | 2022-08-11 ✅ Patent 11,510,889 granted on 2022-11-29
US20220249423A1
Human necessities

Methods for inhibiting the progression of neurodegenerative diseases

 #3 | 2022-08-11 ✅ Patent 11,491,130 granted on 2022-11-08
US20220249422A1
Human necessities

Methods of treating amyotrophic lateral sclerosis

 #4 | 2022-06-07 ✅ Patent 11,351,143 granted on 2022-06-07
US17169271
Human necessities

Methods of treating amyotrophic lateral sclerosis

 #5 | 2021-12-16 ✅ Patent 11,447,441 granted on 2022-09-20
US20210387938A1
Chemistry; metallurgy

Site-specific isotopic labeling of 1,4-diene systems

 #6 | 2021-08-19
US20210252173A1
Human necessities

STABILIZED POLYUNSATURATED COMPOUNDS AND USES THEREOF

 #7 | 2020-04-30 ✅ Patent 11,510,888 granted on 2022-11-29
US20200129467A1
Human necessities

Alleviating oxidative stress disorders with PUFA derivatives

 #8 | 2020-04-09 ✅ Patent 11,453,637 granted on 2022-09-27
US20200109103A1
Chemistry; metallurgy

Site-specific isotopic labeling of 1,4-diene systems

 #9 | 2019-09-19 ✅ Patent 11,166,930 granted on 2021-11-09
US20190282529A1
Human necessities

Isotopically modified components and therapeutic uses thereof

 #10 | 2019-08-01 ✅ Patent 11,241,409 granted on 2022-02-08
US20190231733A1
Human necessities

Neurodegenerative disorders and muscle diseases implicating PUFAs

 #11 | 2019-03-21 ✅ Patent 10,577,304 granted on 2020-03-03
US20190084913A1
Chemistry; metallurgy

Site-specific isotopic labeling of 1,4-diene systems

 #12 | 2019-02-14 ✅ Patent 11,285,125 granted on 2022-03-29
US20190046491A1
Human necessities

Oxidative retinal diseases

 #13 | 2018-11-29 ✅ Patent 10,730,821 granted on 2020-08-04
US20180339958A1
Chemistry; metallurgy

Site-specific isotopic labeling of 1,4-diene systems

 #14 | 2017-06-22 ✅ Patent 10,015,979 granted on 2018-07-10
US20170172195A1
Human necessities

Isotopically modified compounds and their use as food supplements

 #15 | 2014-05-29 ✅ Patent 10,154,983 granted on 2018-12-18
US20140147428A1
Human necessities

Neurodegenerative disorders and muscle diseases implicating PUFAs

 #16 | 2014-05-22 ✅ Patent 8,901,102 granted on 2014-12-02
US20140142059A1
Chemistry; metallurgy

Therapeutic substances that modulate genome methylation

 #17 | 2014-02-20 ✅ Patent 10,154,978 granted on 2018-12-18
US20140050712A1
Human necessities

Disorders implicating PUFA oxidation

 #18 | 2014-02-13 ✅ Patent 10,058,522 granted on 2018-08-28
US20140044693A1
Human necessities

Oxidative retinal diseases

 #19 | 2014-02-13 ✅ Patent 10,058,612 granted on 2018-08-28
US20140044692A1
Human necessities

Impaired energy processing disorders and mitochondrial deficiency

 #20 | 2011-05-05 ✅ Patent 10,052,299 granted on 2018-08-21
US20110105609A1
Human necessities

Alleviating oxidative stress disorders with PUFA derivatives

 #21 | 2011-04-07 ✅ Patent 10,029,956 granted on 2018-07-24
US20110082208A1
Chemistry; metallurgy

Therapies for cancer using isotopically substituted lysine

Also check out RETROTOPE, INC.'s (Los Altos, United States) applicant profile with 16 patent applications submitted.

AssigneeID:

65651 ⎘